Soligenix, Inc. (SNGX) — S-1 Filings
All S-1 filings from Soligenix, Inc.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (3)
-
Soligenix Launches $8M Offering to Dodge Nasdaq Delisting
— Sep 19, 2025 Risk: high
Soligenix, Inc. (SNGX) is conducting an offering of up to $8.0 million in common stock and warrants to address its non-compliance with Nasdaq's minimum stockhol -
Soligenix Files S-1 with SEC
— Jul 24, 2024 Risk: medium
Soligenix, Inc. filed an S-1 form on July 24, 2024, detailing its business and financial status. The company, formerly known as Dor Biopharma Inc. and Immunothe -
Soligenix, Inc. Files S-1 Registration Statement
— Jan 16, 2024 Risk: medium
SOLIGENIX, INC. (SNGX) filed a IPO Registration (S-1) with the SEC on January 16, 2024. Soligenix, Inc. (SNGX) filed an S-1 registration statement with the SEC
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX